A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma (clinicaltrials.gov) - Jul 29, 2026 - P1 | N=36 | Not yet recruiting | Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
New P1 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|